Daniel R. Premkumar

Also affiliated with Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Targeting NAD+ Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance”.

Targeting NAD+ Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance

Molecular Cancer Research(2020)10.1158/1541-7786.mcr-19-0669

N/A

0DataRank · unranked

26 citations

Daniel R. Premkumar, Swetha Thambireddy, Brian Golbourn, Sameer Agnihotri, Kelsey C. Bertrand +8 more

Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome

Nature Cancer(2022)10.1038/s43018-022-00348-3

N/A

0DataRank · unranked

92 citations

Matthew Halbert, Katharine Halligan, Srinidhi Varadharajan, Brian Krug, Nneka E. Mbah +44 more

Author Correction: Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome

Nature Cancer(2022)10.1038/s43018-022-00407-9

N/A

0DataRank · unranked

2 citations

Matthew Halbert, Katharine Halligan, Srinidhi Varadharajan, Brian Krug, Nneka E. Mbah +44 more

An ERK5-PFKFB3 axis regulates glycolysis and represents a therapeutic vulnerability in pediatric diffuse midline glioma

Cell Reports(2023)10.1016/j.celrep.2023.113557

N/A

0DataRank · unranked

17 citations

Taylor Gatesman, Akanksha Chilukuri, Srinidhi Varadharajan, Brenden J. Johnson, Daniel R. Premkumar +39 more

Targeting mitochondrial energetics reverses panobinostat‐ and marizomib‐induced resistance in pediatric and adult high‐grade gliomas

Molecular Oncology(2023)10.1002/1878-0261.13427

N/A

0DataRank · unranked

12 citations

Matthew C. Reslink, Taylor Gatesman, Matthew Halbert, Tracy A. Miller, Brian Golbourn +12 more